Dasatinib + dexamethasone
- 1 lab in 1 country
- Funder: Wilhelm Sander-Stiftung
- Cells1
Outcomes
1BCAR1
downin human cells1
1 study
BCAR1
downin human cells1
Dasatinib + dexamethasone decreases BCAR1 in human cells.
“Dasatinib and Dexamethasone combination treatment showed strong synergistic effects on Src and p130Cas phosphorylation and led to reduced p130Cas expression.”
Cellscombination treatment in TSCC lines
Cell communication and signaling : CCSJun 19, 2025
Latest
1 paper in 12 monthsCell Communication and Signaling
The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity
Experiments in human cellsGlucocorticoids
Stem Cell Research & Therapy
Cellular senescence mediates the detrimental effect of prenatal dexamethasone exposure on postnatal long bone growth in mouse offspring
Experiments in animalsInterventions